Exploiting Strong {Cr III –Dy III } Ferromagnetic Exchange Coupling to Quench Quantum Tunneling of Magnetization in a Novel {Cr III 2 Dy III 3 } Single-Molecule Magnet
Crystal Growth & Design · 04.01.2023 · 23 (1) · 197-206
DOI: 10.1021/acs.cgd.2c00888 ↗Kurz gefasst
Fachartikel in der Zeitschrift Crystal Growth & Design, online erschienen am 21.12.2022. Verfasst von Deepanshu Chauhan und 6 weiteren Autor:innen. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Council of Scientific and Industrial Research, India, University Grants Commission, Science and Engineering Research Board.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- Council of Scientific and Industrial Research, India
- University Grants Commission
- Science and Engineering Research Board
- Australian Research Council
Zitieren
APA
Chauhan, D., Vignesh, K. R., Swain, A., Langley, S. K., Murray, K. S., Shanmugam, M., & Rajaraman, G. (2023). Exploiting Strong {Cr III –Dy III } Ferromagnetic Exchange Coupling to Quench Quantum Tunneling of Magnetization in a Novel {Cr III 2 Dy III 3 } Single-Molecule Magnet. Crystal Growth & Design, 23(1), 197-206. https://doi.org/10.1021/acs.cgd.2c00888
Vancouver
Chauhan D, Vignesh KR, Swain A, Langley SK, Murray KS, Shanmugam M, et al. Exploiting Strong {Cr III –Dy III } Ferromagnetic Exchange Coupling to Quench Quantum Tunneling of Magnetization in a Novel {Cr III 2 Dy III 3 } Single-Molecule Magnet. Crystal Growth & Design. 2023;23(1):197-206. doi:10.1021/acs.cgd.2c00888
BibTeX
@article{Chauhan2023,
author = {Chauhan, Deepanshu and Vignesh, Kuduva R. and Swain, Abinash and Langley, Stuart K. and Murray, Keith S. and Shanmugam, Maheswaran and Rajaraman, Gopalan},
title = {Exploiting Strong Cr III –Dy III Ferromagnetic Exchange Coupling to Quench Quantum Tunneling of Magnetization in a Novel Cr III 2 Dy III 3 Single-Molecule Magnet},
journal = {Crystal Growth & Design},
year = {2023},
volume = {23},
number = {1},
pages = {197--206},
doi = {10.1021/acs.cgd.2c00888}
}
EUVIMED